Home » R&I Project Hub » SEPTON

SEPTON

SECURITY PROTECTION TOOLS FOR NETWORKED MEDICAL DEVICES

Joanne Ahern

01 January 2023

31 December 2025

EC funded project

Network security for medical devices

Networked medical devices, including life-supporting or sustaining devices such as pacemakers, patient monitors and infusion pumps have played a transformational role in healthcare. At the same time, they are vulnerable to hacking and unauthorised access, potentially compromising patient safety. As such, there is an unmet need to address such security risks and safeguard patient health information and safety. The EU-funded SEPTON project aims to develop a cybersecurity toolkit capable of protecting networked medical devices. The approach will incorporate blockchain and machine learning techniques to allow for vulnerability assessment and improved data-exchange security. Results will be applicable in hospitals and other healthcare centres.

Objective

SEPTON aims to address the gap in the generic technologies and processes referring to the IT network infrastructure with a holistic approach towards reinforcing NMD security within the healthcare centre premises. The project will advance cutting-edge solutions in healthcare cybersecurity targeting the aforementioned health providers and particularly focusing on networked medical devices (NMDs). The SEPTON approach will result in a comprehensive cybersecurity toolkit providing tools and mechanisms to be used in hospitals and care centres for a) the protection of networked medical devices, including wearable and implantable devices, and using techniques such as polymorphism b) the secure and privacy preserving data exchanges between NMDs, utilising techniques such as blockchain, differential privacy and encryption c) behavioural anomaly detection, utilising a cybersecurity analytics framework coupled with machine learning techniques and hardware acceleration for increased performance and d) NMD vulnerability assessment. The usability of the proposed solutions will be tested in a realistic setup via extensive pilot trials, facilitated by the participation of two healthcare organisations